Brokerages Set United Therapeutics Co. (NASDAQ:UTHR) PT at $312.22
Shares of United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) have been given an average recommendation of “Moderate Buy” by the ten research firms that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and nine have given a buy recommendation to the company. […]
More Stories
Cheniere Energy Partners (CQP) & Its Competitors Financial Analysis
Cheniere Energy Partners (NYSE:CQP – Get Free Report) is one of 23 publicly-traded companies in the “Natural gas distribution” industry,...
Xos, Inc. (NASDAQ:XOS) Given Consensus Rating of “Moderate Buy” by Brokerages
Shares of Xos, Inc. (NASDAQ:XOS – Get Free Report) have earned a consensus rating of “Moderate Buy” from the six...
Oruka Therapeutics (NASDAQ:ORKA) & Myriad Genetics (NASDAQ:MYGN) Critical Review
Myriad Genetics (NASDAQ:MYGN – Get Free Report) and Oruka Therapeutics (NASDAQ:ORKA – Get Free Report) are both small-cap medical companies,...
AptarGroup, Inc. (NYSE:ATR) Receives $189.50 Average Target Price from Analysts
AptarGroup, Inc. (NYSE:ATR – Get Free Report) has been given an average rating of “Buy” by the seven analysts that...
Comparing VirTra (NASDAQ:VTSI) and Multi Ways (NYSE:MWG)
VirTra (NASDAQ:VTSI – Get Free Report) and Multi Ways (NYSE:MWG – Get Free Report) are both small-cap aerospace companies, but...
CAE Inc. (NYSE:CAE) Given Average Rating of “Hold” by Brokerages
CAE Inc. (NYSE:CAE – Get Free Report) (TSE:CAE) has earned an average recommendation of “Hold” from the nine brokerages that...